Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-25-037466
Filing Date
2025-12-10
Accepted
2025-12-10 21:48:28
Documents
2
Period of Report
2025-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1378
2 poaslosman.htm EX-24 8597
  Complete submission text file 0001437749-25-037466.txt   11671
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Issuer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4 MENORAT HAMAOR ST. C/O INSPIREMD, INC. TEL AVIV L3 6744832
Business Address
Slosman Marvin (Reporting) CIK: 0001796908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38999 | Film No.: 251563363